TrialInternational journal of hematology2015

Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment.

Dao-bin Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.